Strength
37.5 mg/g
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
51672417406
Classification
Generic
Dosage Form
CREAM
Route
TOPICAL
Last Updated
7/23/2025
Active Ingredients
IMIQUIMODApproval Type
Generic (ANDA)
FDA Application
ANDA205971On Market Since
1/26/2021
Pharmacological Classes
Increased Cytokine Activity
Increased Cytokine Production
Interferon Inducers
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.